![The Asian Pacific Association for the Study of the Liver [APASL]](http://apasl.info/app-def/S-102/apasl/wp-content/themes/apasl/images/header/img_apasl_logo.png){kind=logo}
Episode 5-02 May 21, 2021
Search Results of "covid+"
The APASL Hepatology Webinar 3-1 has been successfully held!
Thank you for taking part on our APASL Hepatology Webinar!The video of session 1 is available on APASL YouTube channel. Date: Saturday August 8, 2020Moderators: Dr. Grace Wong (Hong Kong), Dr. Fu-Sheng Wang (Beijing)Topics & SpeakersTopic 1: “Risk of HCC with Anti-HBV Therapy”Speaker 1: Dr. Young-Suk Lim (Korea)Topic 2: “Immunology, Monoclonal Antibodies, and Vaccine Strategies for COVID-19”Speaker 2: Dr. David Watkins (USA)
The APASL Hepatology Webinar 3-4 has been successfully held!
Thank you for taking part on our APASL Hepatology Webinar!The video of session 4 is available on APASL YouTube channel. Date: Saturday August 29, 2020 Topic 1: “Autoimmune Hepatitis” Speaker 1: Dr. Xiong Ma (Shanghai) Topic 2: “Management of Portal Hypertension during COVID-19 Pandemics” Speaker 2: Dr. Xiaolong Qi (Lanzhou) Moderators: Dr. Khin Maung Win (Myanmar) / Dr. Wasim Jafri (Pakistan)
The APASL Hepatology Webinar 2-3 has been successfully held!
Thank you for taking part on our APASL Hepatology Webinar!The video of session 3 is now available on APASL YouTube channel. Topic 1: “Is Taiwan winning COVID-19?” Speaker 1: Dr. Hsiu-Hsi Chen (Taiwan) Topic 2: “Acute-on-chronic Liver Failure – an Update” Speaker 2: Dr. Shiv K Sarin (India)
Invitation to APASL Hepatology Webinar BEST publications in “Hepatology International” Episode 7-3 “ACLF”
Friday, September 29, 2023 at 17:00 (UTC/GMT +08:00) Asia/Beijing It is our great pleasure to invite you to participate in the Asian Pacific Association for the Study of Liver (APASL) Hepatology Webinar Episode 7. Please don’t miss it! Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) Hepatol Int. 2020 Sep;14(5):690-700 Effect of COVID-19 on patients with compensated chronic liver diseases Hepatol Int. 2020 Sep;14(5):701-710 Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury Hepatol Int. 2020 Sep;14(5):733-742 Date Friday, September 29th, 2023 Time 12:00- (GMT+3:00) Istanbul … [Read more]
The APASL Hepatology Webinar 2-7 has been successfully held!
Thank you for taking part on our APASL Hepatology Webinar!The video of session 7 is now available on APASL YouTube channel. Topic 1: “Drug Development for COVID-19” Speaker 1: Dr. Tarik Asselah (France) Topic 2: “Cessation of NUCs in CHB” Speaker 2: Dr. Rachel Wen-Juei Jeng (Taiwan)
Diagnosis and Treatment Protocol of COVID-19 in China
Date April 11 (Sat), 2020 Moderators Shiv K Sarin (India) Diana Payawal (Philippines) Topic Diagnosis and Treatment Protocol of COVID-19 in China Speaker Gui-Qiang Wang (China)
Who have saved the first American from Covid 19?
Date April 18 (Sat), 2020 Moderators Tawesak Tanwandee (Thailand) Jin Mo Yang (South Korea) Topic Who have saved the first American from Covid 19? Speaker Masao Omata (Japan)
Liver injury in Covid 19
Date April 25 (Sat), 2020 Moderators George Lau (China) Teerha Piratvisuth (Thailand) Topic Liver injury in Covid 19 Speaker Shiv K Sarin (India) Manoj Kumar Sharma (India)
Hepatotoxicity of anti-Covid 19 therapy
Date May 16 (Sat), 2020 Moderators Jia-Horng Kao (Taiwan) Lai Wei (China) Topic Hepatotoxicity of anti-Covid 19 therapy Speaker Bin Gao (China) Qin Ning (China)
To understand sytokine storm in COVID-19”
Date May 23 (Sat), 2020 Moderators Laurentius Lesmana (Indonesia) A Kadir Dokmeci (Turkey) Topic To understand sytokine storm in COVID-19 Speaker Antonio Bertoletti (Singapore)
Subscription of Journal
Dear members, Hepatology International extends its Warmest Greetings ! As we step into yet another year of new targets, renewed expectations and hope, with reflections of the successes and limitations of the passing year, we would like to express our sincere thanks and gratitude to all our members who have remained an integral part of the Hepatology International through its journey all these years. The journal, under the able guidance and leadership of Prof Masao Omata and Prof Shiv Sarin, has come a long way since its inception in 2007, establishing itself in the field of Hepatology and Biliary Sciences, earning a place in PubMed and ISI, and achieving a … [Read more]
APASL Webinar
The previous sessions of APASL Hepatology Webinar have been uploaded at APASL Official YouTube. Please subscribe to our APASL channel! APASL Official YouTube https://www.youtube.com/channel/UC9b8afc00_jG9J0GBKmMpeQ APASL COVID-19 Hepatology Task Force has published clinical practice guidance! You can read and download the guidance from This PAGE. May 15, 2020 Dear Colleagues, “We need hope but not false hope”NEVER in the history of mankind should we be more united to confront a common deadly enemy-Covid-19. To win this war for human race, we need knowledge from at all fronts, be united for critical thinking and there should be no room for finger-pointing. Without immunity and any highly effective treatment, we can only anticipate more casualties directly … [Read more]
APASL Hepatology Webinar 5-2 will be held!
Friday, May 21st 2021 at 20:00-21:50 (Korean Standard Time= +9:00 GMT) It is our great pleasure to invite you to participate in the Asian Pacific Association for the Study of Liver (APASL) Hepatology Webinar Episode 5.Topic: “COVID-19 Vaccination in Patients with Liver Disease” Speakers: Dr. Won Suk Choi, Dr. Ki Tae Kwon, Dr. Grace Wong, Dr. Gautam Mehta Moderators: Dr. Masao Omata, Dr. Shiv K Sarin, Dr. Jin-Mo Yang, Dr. George Lau, Dr. Woo-Joo Kim Please do not miss it! Date Friday May 21st, 2021 Time 2:00pm-3:50pm (GMT+3:00) Istanbul 4:00pm-5:50pm (GMT+5:00) Karachi 4:30pm-6:20pm (IST = GMT+5:30) New Delhi 5:30pm-7:20pm (IST = GMT+5:30) Yangon 6:00pm-7:50pm (GMT+7:00) Bangkok / Jakarta … [Read more]
The 1st APASL Hepatology Webinar of episode 3 has been successfully held!
Thank you for taking part on our APASL Hepatology Webinar (episode 3)!The video of session 1 is now available on APASL YouTube channel.You can also find the slides of following presentations below the linked video. Moderators: Dr. Grace Wang (China) / Dr. Fu-Sheng Wang (China) Topic 1: “Risk of HCC with Anti-HBV Therapy”Speaker 1: Dr. Young-Suk Lim (Korea) Topic 2: “Immunology, Monoclonal Antibodies, and Vaccine Strategies for COVID-19”Speaker 2: Dr. David Watkins (USA)
［YouTube］”Research and new drug discovery in HBV- has it taken back seat in COVID-19 era?”
The 7th presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “Research and new drug discovery in HBV- has it taken back seat in COVID-19 era?” Speaker: Dr. Stephen Locarnini You can see the whole slides below the video.
［YouTube］”HBV immunization services during COVID-19 pandemic- Guidance”
The 6th presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “HBV immunization services during COVID-19 pandemic- Guidance” Speaker: Dr. Saeed Hamid You can see the whole slides below the video.
［YouTube］”COVID-19 and viral hepatitis B and C elimination programs: Are we stepping backward?”
The 5th presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “COVID-19 and viral hepatitis B and C elimination programs: Are we stepping backward? “Speaker: Dr. Ji Dong JiaYou can see the whole slides below the video.
![［YouTube］”Selection of treatment modalities in patients infected with chronic HBV in COVID-19 pandemic era [antivirals or interferons] “](http://apasl.info/app-def/S-102/apasl/wp-content/uploads/2020/07/Folie7-7-120x120.jpg "［YouTube］”Selection of treatment modalities in patients infected with chronic HBV in COVID-19 pandemic era [antivirals or interferons] “")
［YouTube］”Selection of treatment modalities in patients infected with chronic HBV in COVID-19 pandemic era [antivirals or interferons] “
The 3rd presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “Selection of treatment modalities in patients infected with chronic HBV in COVID-19 pandemic era [antivirals or interferons]”Speaker: Dr. Tawesak TanwandeeYou can see the whole slides below the video.
［YouTube］”Assessment for treatment candidacy of patients infected with chronic HBV in COVID-19 pandemic era”
The 2nd presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “Assessment for treatment candidacy of patients infected with chronic HBV in COVID-19 pandemic era”Speaker: Dr. Anna Lok You can see the whole slides below the video.